To readers by R. A. Khamitov

Get full text

Implementation of the quality-by-design concept for an adeno-associated viral vector-based gene therapy by D. S. Kopein, G. N. Poroshin, R. A. Khamitov

Get full text

Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome by S. Ya. Loginova, V. N. Shchukina, S. V. Borisevich, R. A. Khamitov, V. A. Maksimov, A. M. Shuster

Get full text

Validation of a test procedure for determination of specific activity of human recombinant interferon beta (Infibeta®) using various cell/virus combinations by Yu. N. Lebedeva, N. A. Litvinova, T. N. Lobanova, R. R. Shukurov, R. A. Khamitov, L. A. Gaiderova

Get full text

Comparative safety evaluation of intranasal and intramuscular immunisation with Ad26 and Ad5-vectored vaccines to prevent coronavirus infection by E. V. Zuev, O. L. Evdokimova, O. A. Markova, I. A. Korotkevich, T. V. Grigorieva, R. A. Khamitov

Get full text

Physico-Chemical and Biological Properties of Biosimilar and Reference Tissue Plasminogen Activator Products by V. D. Gusarova, M. S. Pantyushenko, V. M. Simonov, R. R. Shukurov, R. A. Khamitov, A. Yu. Vishnevskiy

Get full text

An experience of scaling and intensifying the industrial production of the Gam-COVID-Vac vector adenovirus vaccine in the limiting conditions of the pandemic by A. N. Morozov, I. R. Yakhin, N. V. Stratonova, M. V. Kutskir, D. A. Poteryaev, R. A. Khamitov

Get full text

Optimisation of culture conditions for a producer clone coexpressing arylsulfatase B and a formylglycine-generating enzyme in order to increase the yield of arylsulfatase B by S. S. Timonova, K. A. Smolova, I. A. Kirik, M. S. Pantyushenko, R. L. Anisimov, R. A. Khamitov, A. A. Piskunov, V. N. Bade

Get full text

The Creation of Technological Lines for the Cultivation of Modified Lines of Mammalian Cells Expressing Recombinant Proteins by I. A. Churkin, S. V. Borisevich, D. A. Kutaev, V. T. Lymar, Yu. I. Pashchenko, E. V. Gordeev, V. S. Kulish, T. M. Plekhanova, R. A. Khamitov, E. N. Sautkina

Get full text

Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III by E. V. Akatova, Yu. S. Bakhareva, O. V. Bugrova, I. B. Vinogradova, E. V. Gerasimova, Yu. E. Drevina, O. B. Ershova, E. V. Zonova, Yu. I. Ivanova, E. P. Ilivanova, M. M. Kostik, D. G. Krechikova, D. A. Kusevich, A. L. Maslyansky, A. D. Meshkov, N. S. Mosesova, K. A. Nagornova, D. V. Nosovich, S. A. Polyakova, T. A. Popova, E. A. Smolyarchuk, V. N. Sorotskaya, Yu. G. Shvarts, L. N. Shilova, M. S. Shostak, I. Yu. Yunonin, N. E. Akhtyamova-Givirovskaya, R. A. Khamitov, O. A. Markova, E. I. Zagoruiko, E. V. Zuev

Get full text